Levonorgestrel API Market Size was valued at USD 52.01 Mn in 2023 and is predicted to reach USD 71.37 Mn by 2031 at a 4.13% CAGR during the forecast period for 2024-2031.
Levonorgestrel is a medicine that is mostly prescribed for the purpose of preventing pregnancy. There are many ways to actively use this hormone drug to control birth. If all other methods of preventing pregnancy have been exhausted, an emergency contraceptive may be utilized. It stops eggs from follicular attachment as well. One of the best ways to prevent unwanted pregnancies is by using this strategy. The rise of chronic diseases, the need for more individualized treatments, and innovative drug delivery systems are just a few of the factors that experts predict will drive the active pharmaceutical component industry forward. The intrauterine system (IUS), which stands for levonorgestrel-releasing intrauterine system, is easily reversible. Additionally, it keeps working for a long time. The fact that it combines the benefits of hormonal and intrauterine contraception is a bonus to its already impressive efficiency. This has played a role in the growth of the levonorgestrel API industry.
However, the market growth is hampered by the high-cost criteria for the safety and health of the levonorgestrel API market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high levonorgestrel API because potential problems with intermittency and reliability are noticeable in certain Levonorgestrel API solutions, such as wind and solar power. They become more problematic in areas where weather patterns are unexpected. Levonorgestrel API solutions, especially for large-scale applications, need a big upfront expenditure, which is a major obstacle to industry expansion. The COVID-19 pandemic and the supply chain disruptions it caused, such as manufacturing closures and constraints, have caused sales of API commodities to decline.
The levonorgestrel API market is segmented based on type and application. Based on type, the market is segmented into short-acting contraceptive API and long-acting contraceptive API. By application, the market is segmented into levonorgestrel tablets, mixture products, and hormone-releasing IUDs.
The short-acting contraceptive API segment is expected to hold a major global market share in 2023. Short-acting contraceptives, such as oral contraceptive pills and injectables, are widely used methods of birth control due to their convenience and effectiveness. This high demand drives the need for levonorgestrel APIs, which are a key component in many of these contraceptive products. Levonorgestrel is a progestin hormone commonly used in various forms of contraceptives because of its efficacy in preventing pregnancy. Its effectiveness contributes to its widespread usage in short-acting contraceptives, further bolstering the demand for levonorgestrel APIs.
The hormone-releasing IUD industry makes up the bulk of acrylic acid ester usage because the hormone progesterone is produced naturally by the human body and is remarkably similar to progestin. While utilizing an intrauterine device (IUD), the hormones might alleviate heavy or painful periods in addition to preventing pregnancy, especially in countries like the US, Germany, the UK, China, and India.
The North American levonorgestrel API market is expected to register the highest revenue share in the near future. This can be attributed to the robust system of medical care and the rising healthcare costs. In addition, Asia Pacific is projected to grow rapidly in the global Levonorgestrel API Market due to the increasing number of women in the population, the prevalence of strong and stringent policies for the payment of contraceptives, and the rates of fertility.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 52.01 Mn |
|
Revenue Forecast In 2031 |
USD 71.37 Mn |
|
Growth Rate CAGR |
CAGR of 4.13% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, By Application and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Bayer HealthCare, Qinhuangdao Zizhu Pharmaceutical, Yangzhou Pharmaceutical, Lupin, Hubei Gedian Humanwell, Sterling Spa, Formos, Huazhong Pharm, and ASG Biochem |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Levonorgestrel API Market Snapshot
Chapter 4. Global Levonorgestrel API Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Short-Acting Contraceptive API
5.2.2. Long-Acting Contraceptive API
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Levonorgestrel Tablet
6.2.2. Mixture Products
6.2.3. Hormone-Releasing IUD
Chapter 7. Levonorgestrel API Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.1.2. North America Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.1.3. North America Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.2.2. Europe Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.2.3. Europe Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.3.2. Asia Pacific Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.3.3. Asia Pacific Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.4.2. Latin America Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.4.3. Latin America Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.5.2. Middle East & Africa Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.5.3. Middle East & Africa Levonorgestrel API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Bayer HealthCare (Germany)
8.2.2. Qinhuangdao Zizhu Pharmaceutical (China)
8.2.3. Yangzhou Pharmaceutical (China)
8.2.4. Lupin (India)
8.2.5. Hubei Gedian Humanwell (China)
8.2.6. Sterling Spa (U.S.)
8.2.7. Formos (Canada)
8.2.8. Huazhong Pharm (China)
8.2.9. ASG Biochem (U.S.)
8.2.10. Other Prominent Players
Levonorgestrel API Market-By Type
Levonorgestrel API Market-By Application
Levonorgestrel API Market-By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
